HIGHLIGHTS
- who: Pancreatic Cancer and colleagues from the Department of Laboratory Medicine, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China have published the research work: Codelivery of Doxorubicin/PI3K Inhibitor Nanomicelle Linked with Phenylboronic Acid for Enhanced Cytotoxicity to Pancreatic Cancer, in the Journal: Journal of Nanomaterials 100 of 23/06/2022
- how: The authors used phenylboronic acid and polyethylene glycol as materials of nanomicelles loaded with the PI3K/mTORC1 dual inhibitor PF04691502 (PF) to inhibit the resistance and metastasis of and increase the sensitivity of doxorubicin (DOX). The results showed that the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.